Sort
64,565 grants matching “drug discovery”
Harvard-wide Program on Antibiotic Resistance
$1,980,896Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2017 · AI
CENTER FOR CANCER EXPERIMENTAL THERAPEUTICS
$1,980,477University Of Kansas Lawrence · P20 · FY2002 · RR
Small molecule inhibitors of CAPON-induced tau aggregation
$1,980,378Moustafa Gabr · Weill Medical Coll Of Cornell Univ · RF1 · FY2024 · AG
Orbitrap Astral to support investigator proteomics research in a Core facility.
$1,980,309Tukiet T Lam · Yale University · S10 · FY2025 · OD
ADULT AIDS CLINICAL TRIALS UNIT
$1,980,025Ohio State University · U01 · FY2005 · AI
Identification of Cell Type-Specific Actions of Antipsychotic Drugs
$1,979,996Paul Greengard · Rockefeller University · P50 · FY2012 · MH
Identification of Cell Type-Specific Actions of Antipsychotic Drugs
$1,979,996Paul Greengard · Rockefeller University · P50 · FY2014 · MH
PAAR-Pharmacogenomics of Anticancer Agents Research Group
$1,979,869Mark J Ratain · University Of Chicago · U01 · FY2012 · GM
Molecular Targets COBRE
$1,978,806Donald M Miller · University Of Louisville · P20 · FY2008 · RR
Identification of Cell Type-Specific Actions of Antipsychotic Drugs
$1,978,310Paul Greengard · Rockefeller University · P50 · FY2011 · MH
CENTER FOR CANCER EXPERIMENTAL THERAPEUTICS
$1,978,280University Of Kansas Lawrence · P20 · FY2003 · RR
Initiation of DNA Replication in Mammalian Cells
$1,977,132Mirit Aladjem · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SPORE in Ovarian Cancer
$1,976,958Ie-Ming Shih · Johns Hopkins University · P50 · FY2020 · CA
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,976,439Julie A. Johnson · University Of Florida · U01 · FY2011 · GM
CENTER FOR CANCER EXPERIMENTAL THERAPEUTICS
$1,976,012University Of Kansas Lawrence · P20 · FY2004 · RR
Harvard-wide Program on Antibiotic Resistance
$1,975,237Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2019 · AI
Pharmacogenomic Evaluation of Antihypertensive Responses
$1,975,100Julie A. Johnson · University Of Florida · U01 · FY2014 · GM
Data Coordination Center for PDX Net
$1,974,874Jeffrey Hsu-Min Chuang · Jackson Laboratory · U24 · FY2017 · CA
DEVELOPMENTAL BIOLOGY OF HUMAN ERYTHROPOIESIS
$1,974,140Stuart H Orkin · Boston Children'S Hospital · P01 · FY2015 · HL
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
$1,973,398James C Sacchettini · Texas A&M University · P01 · FY2012 · AI
Therapeutics for inflammatory bowel disease from the microbiome
$1,973,386Sarkis K Mazmanian · Symbiotix Biotherapies, Inc. · R42 · FY2016 · DK
Development of novel therapeutics for opioid dependence
$1,972,485Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UH3 · FY2021 · DA
Development of novel therapeutics for opioid dependence
$1,972,485Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UH3 · FY2022 · DA
Development of novel therapeutics for opioid dependence
$1,972,485Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UG3 · FY2019 · DA
Development of novel therapeutics for opioid dependence
$1,972,485Paul J Kenny · Icahn School Of Medicine At Mount Sinai · UH3 · FY2020 · DA